Unproven stem cell interventions: A global public health problem requiring global deliberation

dc.contributor.authorMaster, Zubinen_US
dc.contributor.authorMatthews, Kirstin R.W.en_US
dc.contributor.authorAbou-el-Enein, Mohameden_US
dc.contributor.orgJames A. Baker III Institute for Public Policyen_US
dc.date.accessioned2023-04-05T16:04:52Zen_US
dc.date.available2023-04-05T16:04:52Zen_US
dc.date.issued2021en_US
dc.description.abstractThe unproven stem cell intervention (SCI) industry is a global health problem. Despite efforts of some nations, the industry continues to flourish. In this paper, we call for a global approach and the establishment of a World Health Organization (WHO) Expert Advisory Committee on Regenerative Medicine to tackle this issue and provide guidance. The WHO committee can harmonize national regulations; promote regulatory approaches responsive to unmet patient needs; and formulate an education campaign against misinformation. Fostering an international dialog and developing recommendations that can be adopted by member states would effectively address the global market of unproven SCIs.en_US
dc.identifier.citationMaster, Zubin, Matthews, Kirstin R.W. and Abou-el-Enein, Mohamed. "Unproven stem cell interventions: A global public health problem requiring global deliberation." <i>Stem Cell Reports,</i> 16, no. 6 (2021) Cell Press: 1435-1445. https://doi.org/10.1016/j.stemcr.2021.05.004.en_US
dc.identifier.digital1-s2-0-S2213671121002551-mainen_US
dc.identifier.urihttps://hdl.handle.net/1911/114546en_US
dc.titleUnproven stem cell interventions: A global public health problem requiring global deliberationen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
1-s2-0-S2213671121002551-main.pdf
Size:
758.26 KB
Format:
Adobe Portable Document Format